The THRIVE Beyond Glycemic Control Initiative: A Spotlight on Hypoglycemia: Reducing Risks Without Compromising Glycemic Control

View Activity

COURSE DIRECTOR

Vivian Fonseca, MD
Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

FACULTY PRESENTER

Mark E. Molitch, MD
Martha Leland Sherwin Professor of Endocrinology
Division of Endocrinology, Metabolism and Molecular Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

PROGRAM OVERVIEW

This enduring activity will cover ways in which the healthcare team can minimize the risk for hypoglycemia in patients with type 2 diabetes. Specifically, our aims will be to review the consequences of hypoglycemia; discuss approaches to assessing symptomatic and asymptomatic risk of hypoglycemia; assess anti-diabetes therapies and how to balance their safety and efficacy to reduce hypoglycemia; and evaluate nonpharmacological strategies for lowering risk.

TARGET AUDIENCE

This educational activity is intended for primary care physicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators and other HCPs who care for patients with diabetes.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Review the short- and long-term consequences of hypoglycemia as it relates to patients and providers.
  • Determine how various insulin formulations may increase or decrease the risk of hypoglycemia.
  • Discuss approaches to assessing the risk of symptomatic and asymptomatic hypoglycemia in individual patients.
  • Evaluate nonpharmacological strategies for minimizing the risk of hypoglycemia.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with diabetes.
Credits: 1.0 ANCC Contact Hour.

CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Fonseca conducts research for Bayer and Boehringer Ingelheim. He is a consultant for Takeda, Novo Nordisk, Sanofi- Aventis, Eli, Abbott, Astra- Zeneca, Intarcia, and Asahi. Dr. Fonseca has stock options in Microbiome Technologies, Insulin Algorithms, BRAVO4Health, and stock in Amgen.

Dr. Molitch is a consultant for Novartis, Sanofi, Janssen, Merck, and Pfizer and a grant recipient for Novartis and Bayer.

CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Chris Drury, Medical Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Jessica McMullen, MPH, Program Manager for Med Learning Group, has nothing to disclose.
Brianna Hanson, Accreditation and Outcomes Coordinator, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to Med Learning Group.
You will receive your certificate upon completion of your evaluation form, as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at; info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: September 27, 2019

EXPIRATION DATE: September 27, 2020

View Activity

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.